Technical Analysis for BIO.B - Bio-Rad Laboratories, Inc. Class B

Grade Last Price % Change Price Change
grade D 218.3 -2.04% -4.55
BIO.B closed down 2.04 percent on Wednesday, October 18, 2017, on 1.13 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Earnings due: Nov 7

Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical BIO.B trend table...

Date Alert Name Type % Chg
Oct 18 Narrow Range Bar Range Contraction 0.00%
Oct 18 Lower Bollinger Band Walk Other 0.00%
Oct 18 MACD Bearish Centerline Cross Bearish 0.00%
Oct 18 Calm After Storm Range Contraction 0.00%
Oct 17 Narrow Range Bar Range Contraction -2.04%

Older signals for BIO.B ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network worldwide. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Is BIO.B a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 240.5
52 Week Low 149.45
Average Volume 106
200-Day Moving Average 208.8814
50-Day Moving Average 223.0978
20-Day Moving Average 227.0085
10-Day Moving Average 226.007
Average True Range 2.12
ADX 39.76
+DI 11.35
-DI 34.32
Chandelier Exit (Long, 3 ATRs ) 223.79
Chandelier Exit (Short, 3 ATRs ) 224.66
Upper Bollinger Band 232.0578
Lower Bollinger Band 221.9592
Percent B (%b) -0.36
BandWidth 4.448556
MACD Line -0.1588
MACD Signal Line 0.9538
MACD Histogram -1.1127
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 218.30
Resistance 3 (R3) 218.30 218.30 218.30
Resistance 2 (R2) 218.30 218.30 218.30 218.30
Resistance 1 (R1) 218.30 218.30 218.30 218.30 218.30
Pivot Point 218.30 218.30 218.30 218.30 218.30
Support 1 (S1) 218.30 218.30 218.30 218.30 218.30
Support 2 (S2) 218.30 218.30 218.30 218.30
Support 3 (S3) 218.30 218.30 218.30
Support 4 (S4) 218.30